92 related articles for article (PubMed ID: 19068015)
1. Bofu-tsusho-san effectively attenuates the weight gain observed after receiving olanzapine.
Yamamoto N; Inada T
Psychiatry Clin Neurosci; 2008 Dec; 62(6):747. PubMed ID: 19068015
[No Abstract] [Full Text] [Related]
2. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
[TBL] [Abstract][Full Text] [Related]
3. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ
BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317
[TBL] [Abstract][Full Text] [Related]
4. Aripiprazole for the management of olanzapine-induced weight gain.
Englisch S; Weinbrenner A; Inta D; Zink M
Pharmacopsychiatry; 2009 Jul; 42(4):166-7. PubMed ID: 19585397
[No Abstract] [Full Text] [Related]
5. The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients.
Poyurovsky M; Pashinian A; Levi A; Weizman R; Weizman A
Int Clin Psychopharmacol; 2005 Mar; 20(2):101-3. PubMed ID: 15729086
[TBL] [Abstract][Full Text] [Related]
6. Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate.
Lin YH; Liu CY; Hsiao MC
Psychiatry Clin Neurosci; 2005 Oct; 59(5):613-5. PubMed ID: 16194268
[TBL] [Abstract][Full Text] [Related]
7. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
McQuade RD; Stock E; Marcus R; Jody D; Gharbia NA; Vanveggel S; Archibald D; Carson WH
J Clin Psychiatry; 2004; 65 Suppl 18():47-56. PubMed ID: 15600384
[TBL] [Abstract][Full Text] [Related]
8. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
Saddichha S; Ameen S; Akhtar S
J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of the histamine receptor (H1HR) gene are not associated with olanzapine-induced weight gain.
Godlewska BR; Olajossy-Hilkesberger L; Olajossy M; Limon J; Landowski J
J Clin Psychopharmacol; 2013 Jun; 33(3):436-7. PubMed ID: 23609395
[No Abstract] [Full Text] [Related]
10. Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis.
Strassnig M; Miewald J; Keshavan M; Ganguli R
Schizophr Res; 2007 Jul; 93(1-3):90-8. PubMed ID: 17478082
[TBL] [Abstract][Full Text] [Related]
11. An open trial of olanzapine in children and adolescents with Asperger Disorder.
Milin R; Simeon JG; Batth S; Thatte S; Dare GJ; Walker S
J Clin Psychopharmacol; 2006 Feb; 26(1):90-2. PubMed ID: 16415715
[No Abstract] [Full Text] [Related]
12. Olanzapine and weight gain.
Isaac MB; Isaac MT
Am J Psychiatry; 2005 Sep; 162(9):1764-5; author reply 1765. PubMed ID: 16135655
[No Abstract] [Full Text] [Related]
13. Hypertriglyceridemia associated with direct effects of olanzapine rather than with weight gain: a case report.
Markham-Abedi C; de Leon J
J Clin Psychiatry; 2006 Sep; 67(9):1473-4. PubMed ID: 17017841
[No Abstract] [Full Text] [Related]
14. Orally disintegrating olanzapine and potential differences in treatment-emergent weight gain.
Karagianis J; Hoffmann VP; Arranz B; Treuer T; Maguire GA; de Haan L; Chawla B
Hum Psychopharmacol; 2008 Jun; 23(4):275-81. PubMed ID: 18338426
[TBL] [Abstract][Full Text] [Related]
15. The effect of famotidine addition on olanzapine-induced weight gain in first-episode schizophrenia patients: a double-blind placebo-controlled pilot study.
Poyurovsky M; Tal V; Maayan R; Gil-Ad I; Fuchs C; Weizman A
Eur Neuropsychopharmacol; 2004 Aug; 14(4):332-6. PubMed ID: 15163444
[TBL] [Abstract][Full Text] [Related]
16. Is olanzapine a brain-sparing medication?
Joober R; Schmitz N; Malla A; Sengupta S; Karma S
Arch Gen Psychiatry; 2006 Nov; 63(11):1292. PubMed ID: 17088510
[No Abstract] [Full Text] [Related]
17. Antipsychotic drugs and schizophrenia.
Duan N; Kraemer HC; Mintz J
N Engl J Med; 2006 Jan; 354(3):298-300; author reply 298-300. PubMed ID: 16422019
[No Abstract] [Full Text] [Related]
18. Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients.
Chen CH; Huang MC; Lu ML
J Clin Psychopharmacol; 2007 Oct; 27(5):516-7. PubMed ID: 17873689
[No Abstract] [Full Text] [Related]
19. Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study.
Poyurovsky M; Isaacs I; Fuchs C; Schneidman M; Faragian S; Weizman R; Weizman A
Am J Psychiatry; 2003 Feb; 160(2):297-302. PubMed ID: 12562576
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine increases plasma ghrelin level in patients with schizophrenia.
Murashita M; Kusumi I; Inoue T; Takahashi Y; Hosoda H; Kangawa K; Koyama T
Psychoneuroendocrinology; 2005 Jan; 30(1):106-10. PubMed ID: 15358448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
